Prognostic Value of Molecular Markers for Guiding Post-Remission Therapy in Patients with De Novo Acute Myeloid Leukemia (AML) and Intermediate-Risk Cytogenetics.

被引：0
|
作者：
Pratcorona, Marta [1 ]
Camos, Mireia [2 ]
Torrebadell, Montserrat [2 ]
Rozman, Maria [2 ]
Carrio, Ana [2 ]
Costa, Dolors [2 ]
Valera, Alexandra [2 ]
Campo, Elias [2 ]
Montserrat, Emili [1 ]
Esteve, Jordi [1 ]
机构：
[1] Univ Barcelona, IDIBAPS, Hosp Clin, Inst Hematol & Oncol,Dept Hematol, Barcelona, Spain
[2] Univ Barcelona, IDIBAPS, Hosp Clin, Hematopathol Unit, Barcelona, Spain
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：875 / 876
页数：2
相关论文
共 50 条
  • [41] Elderly patients with de novo acute myeloid leukemia (AML):: Prognostic factors in 132 cases.
    Luno, Elisa
    Sanzo, Carmen
    Jonte, Fermin
    Vicente, Jose Maria
    Carrera, Dolores
    Sole, Francesc
    Chamorro, Pablo
    Martinez, Araceli
    BLOOD, 2006, 108 (11) : 192B - 192B
  • [42] The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics
    J How
    J Sykes
    M D Minden
    V Gupta
    K W L Yee
    A D Schimmer
    A C Schuh
    S Kamel-Reid
    J M Brandwein
    Blood Cancer Journal, 2013, 3 : e116 - e116
  • [43] The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics
    How, J.
    Sykes, J.
    Minden, M. D.
    Gupta, V.
    Yee, K. W. L.
    Schimmer, A. D.
    Schuh, A. C.
    Kamel-Reid, S.
    Brandwein, J. M.
    BLOOD CANCER JOURNAL, 2013, 3 : e116 - e116
  • [44] Impact of Post-Remission Maintenance Therapy (MT) on Outcomes in Patients (pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) in Real-World Practice
    Potluri, Ravi
    Rotter, David
    Kiendrebeogo, Zephirin
    Chen, Clara
    BLOOD, 2021, 138
  • [45] A novel post-remission consolidation regimen for patients with acute myeloid leukemia (AML) <60 years old with normal or unfavorable cytogenetics:: Results from CALGB 9621.
    Kolitz, JE
    George, SL
    Barrier, R
    Hoke, E
    Hurd, DD
    Velez-Garcia, E
    Powell, BL
    Marcucci, G
    Brooks, PL
    Carroll, AJ
    Caligiuri, MA
    Vardiman, JW
    Bloomfield, CD
    Larson, RA
    BLOOD, 2003, 102 (11) : 175A - 175A
  • [46] PROGNOSTIC VALUE OF THE ALLELIC BURDEN OF FLT3 INTERNAL TANDEM DUPLICATION IN PATIENTS WITH INTERMEDIATE-RISK CYTOGENETICS ACUTE MYELOID LEUKEMIA DEPENDS ON UNDERLYING MUTATIONAL STATUS OF NPM
    Pratcorona, M.
    Brunet, S.
    Nomdedeu, J.
    Torrebadell, M.
    Ribera, J. M.
    Tormo, M.
    Duarte, R.
    Escoda, L.
    Guardia, R.
    Queipo de Llano, M. P.
    Salamero, O.
    Pedro, C.
    Marti, J. M.
    Diaz-Beya, M.
    Sierra, J.
    Esteve, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 24 - 25
  • [47] NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients
    Pallares, Victor
    Hoyos, Montserrat
    Carmen Chillon, M.
    Barragan, Eva
    Prieto Conde, M. Isabel
    Llop, Marta
    Virtudes Cespedes, Maria
    Nomdedeu, Josep F.
    Brunet, Salut
    Angel Sanz, Miguel
    Gonzalez-Diaz, Marcos
    Sierra, Jorge
    Casanova, Isolda
    Mangues, Ramon
    ONCOTARGET, 2017, 8 (44) : 76003 - 76014
  • [48] MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia
    Diaz-Beya, M.
    Brunet, S.
    Nomdedeu, J.
    Tejero, R.
    Diaz, T.
    Pratcorona, M.
    Tormo, M.
    Ribera, J. M.
    Escoda, L.
    Duarte, R.
    Gallardo, D.
    Heras, I.
    de Llano, M. P. Queipo
    Bargay, J.
    Monzo, M.
    Sierra, J.
    Navarro, A.
    Esteve, J.
    LEUKEMIA, 2014, 28 (04) : 804 - 812
  • [49] MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia
    M Díaz-Beyá
    S Brunet
    J Nomdedéu
    R Tejero
    T Díaz
    M Pratcorona
    M Tormo
    J M Ribera
    L Escoda
    R Duarte
    D Gallardo
    I Heras
    M P Queipo de Llano
    J Bargay
    M Monzo
    J Sierra
    A Navarro
    J Esteve
    Leukemia, 2014, 28 : 804 - 812
  • [50] Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years
    Cornelissen, J. J.
    Versluis, J.
    Passweg, J. R.
    van Putten, W. L. J.
    Manz, M. G.
    Maertens, J.
    Bverloo, H. B.
    Valk, P. J. M.
    Kooy, M. van Marwijk
    Wijermans, P. W.
    Schaafsma, M. R.
    Biemond, B. J.
    Vekemans, M-C
    Breems, D. A.
    Verdonck, L. F.
    Fey, M. F.
    Jongen-Lavrencic, M.
    Janssen, J. J. W. M.
    Huls, G.
    Kuball, J.
    Pabst, T.
    Graux, C.
    Schouten, H. C.
    Gratwohl, A.
    Vellenga, E.
    Ossenkoppele, G.
    Loewenberg, B.
    LEUKEMIA, 2015, 29 (05) : 1041 - 1050
12345